Price Over Earnings Overview: Gilead Sciences
Portfolio Pulse from Benzinga Insights
Gilead Sciences Inc.'s (NASDAQ:GILD) share price is currently at $77.52, after a 0.42% increase. Over the past month, the stock fell by 0.25%, but it spiked by 24.78% in the past year. The company's P/E ratio of 17.46 is lower than the Biotechnology industry average of 48.76, which could indicate that the stock is undervalued or that shareholders do not expect future growth.
July 17, 2023 | 8:00 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Gilead Sciences' share price is at $77.52, up 0.42%. Its P/E ratio of 17.46 is lower than the Biotech industry average, suggesting potential undervaluation or low growth expectations.
Gilead Sciences' P/E ratio is lower than the industry average, which could indicate that the stock is undervalued. However, it could also suggest that shareholders do not expect the company to perform better in the future. This uncertainty makes the short-term impact on the stock neutral.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100